Position in ALXO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$212,245
+$92,626 QoQ
Shares Held
105,858
0.0% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 68 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF NOVA SCOTIA holds $148,137,503 across 17 Biotechnology names. ALXO ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
97,520 | $75,347,852 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
1,310,387 | $36,297,719 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,361 | $15,790,100 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
135,960 | $8,524,692 | |
| 5 | INCY |
Incyte Corp
|
27,500 | $2,588,300 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,798 | $2,580,124 | |
| 7 | INSM |
INSMED Inc
|
15,203 | $2,485,994 | |
| 8 | ANTX |
AN2 Therapeutics, Inc.
|
459,194 | $1,570,443 |
All Filings in ALXO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $212,245 | 105,858 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $119,619 | 105,858 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $193,720 | 105,858 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $43,931 | 105,858 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $65,949 | 105,858 | Shares | Sole | 2025-07-02 | |
| 2024-12-31 | $175,861 | 105,306 | Shares | Sole | 2025-07-02 | |
| No filing history on record for this holder in this stock. | ||||||